FDA approves focused ultrasound treatment
The US FDA has approved the next generation Exablate system from Israel’s InSightec to treat symptomatic uterine fibroids. Exablate uses focused ultrasound plus MRI, which is used to guide the ultrasound waves to the specific target tissue. Also (TY UWI) a video of Israeli doctors using InSightec’s Exablate Neuro ultrasound to cure Essential Tremor.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink